Cornerstone Planning Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.1K | Sell |
115
-10
| -8% | -$3.75K | 0.01% | 266 |
|
|
2025
Q1 | $61.6K | Buy |
125
+66
| +112% | +$32.5K | 0.01% | 201 |
|
|
2024
Q4 | $26.2K | Buy |
59
+1
| +2% | +$444 | 0.01% | 271 |
|
|
2024
Q3 | $27.3K | Sell |
58
-21
| -27% | -$9.88K | 0.01% | 259 |
|
|
2024
Q2 | $37.7K | Sell |
79
-12
| -13% | -$5.72K | 0.01% | 232 |
|
|
2024
Q1 | $36.5K | Sell |
91
-47
| -34% | -$18.9K | 0.01% | 210 |
|
|
2023
Q4 | $56.2K | Buy |
138
+42
| +44% | +$17.1K | 0.02% | 170 |
|
|
2023
Q3 | $33.4K | Buy |
96
+1
| +1% | +$348 | 0.01% | 236 |
|
|
2023
Q2 | $33.4K | Buy |
+95
| New | +$33.4K | 0.01% | 321 |
|
|
2022
Q4 | $13.2K | Buy |
+43
| New | +$13.2K | 0.01% | 556 |
|